Bristol-Myers Squibb to Close Manufacturing Facility in Ireland

By Pharma News - DCAT Publisher

March 7, 2014

Bristol-Myers Squibb will close its manufacturing facility in Cruiserath, Co. Dublin by the end of 2015, impacting 130 employees.The decision to close the Cruiserath facility reflects the changing market demand for a number of products manufactured at the site. Bristol-Myers Squibb will continue manufacturing at the facility until the end of 2015, according to a company spokesperson.

The company's other manufacturing facility in Swords Co. Dublin will continue operations, but a single operating unit will cease manufacturing by the end of 2015, impacting 30 employees. The closure of this operating unit in Swords is part of ongoing optimization in the company's manufacturing network. Going forward the Swords facility, employing over 320 people, will remain a  supplier of bulk pharmaceuticals. The company is working with IDA Ireland to explore potential future uses of the Cruiserath facility and will endeavor to minimize job losses in Ireland.

Source: Bristol-Myers Squibb